TECX — Tectonic Therapeutic Share News
0.000.00%
Last trade - 00:00- $412.30m
- $185.41m
Brief: Avrobio Announces Leadership Transition
U.S. RESEARCH ROUNDUP- General Mills, McDonald's, Wells Fargo & Co
Avrobio Inc Reports Results For The Quarter Ended In December: Earnings Summary
Brief: Avrobio Reports Fourth Quarter And Fiscal Year 2022 Financial Results
Avrobio Inc Expected To Post A Loss Of 49 Cents A Share: Earnings Preview
Brief: Avrobio Inc - On Feb 23, Received Notice From Nasdaq Notifying Co That Company Has Regained Compliance With The Minimum Bid Price Requirement
Brief: AVROBIO To Present Clinical And Preclinical Data From Lysosomal Disorder Gene Therapy Pipeline
U.S. RESEARCH ROUNDUP- Churchill Downs, Mirati Therapeutics, Vivint Smart Home
U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Solaredge Technologies
U.S. STOCKS ON THE MOVE-Uniti Group, Pfizer, Moleculin Biotech
U.S. STOCKS ON THE MOVE-Prometheus, Pinterest, Roivant
AVROBIO rises on positive results from Gaucher disease gene therapy study
Brief: Avrobio To Share Comprehensive Gaucher Disease Program Update
Brief: Avrobio Inc Files For Mixed Shelf Of Up To $250 Million - SEC Filing
Avrobio Inc Reports Results For The Quarter Ended In September: Earnings Summary
Brief: Avrobio Reports Third Quarter Financial Results
Avrobio Inc Expected To Post A Loss Of 55 Cents A Share: Earnings Preview
Avrobio Inc Expected To Post A Loss Of 55 Cents A Share: Earnings Preview
Brief: Avrobio Receives Rare Pediatric Disease Designation From The U.S. FDA For First-In-Class Gene Therapy For Gaucher Disease